Skip to content
Open access

Therapist-guided and self-guided internet-based behavioural activation versus treatment as usual for adolescents with depression: randomised controlled trial with economic evaluation

Aug 2026 · BMJ mental health · Vol 29, pp. e302619 · 0 citations · 54 references
Medicine

TL;DR

Therapist-guided I-BA reduced depressive symptoms at lower cost than TAU, but clinical importance and robustness are uncertain; baseline-adjusted analyses favoured both I-BA arms.

Abstract

Abstract Background Adolescent depression is a major public health concern with limited access to effective treatments. Behavioural activation (BA) is a suitable intervention for digital delivery, but definitive adolescent trials are scarce. Objective To evaluate whether therapist-guided and self-guided internet-based BA (I-BA) are more efficacious and cost-effective than treatment as usual (TAU) for adolescents with mild to moderate major depressive disorder (MDD). Methods Single-blinded, parallel-group randomised controlled trial with economic evaluation. A total of 219 adolescents (13–17 years) with mild-moderate MDD were randomised (1:1:1) to 10 weeks of therapist-guided I-BA, self-guided I-BA or TAU. Both I-BA interventions included adolescent and parent modules. Primary outcome: change in depression severity (Children’s Depression Rating Scale-Revised, CDRS-R, range 17–113) from baseline to 3-month follow-up (primary endpoint), assessed by blinded evaluators. Analyses included all randomised participants, with statisticians blinded to allocation. A health economic evaluation was performed at the primary endpoint. Findings Baseline CDRS-R indicated clinically significant depression (mean 57.1, threshold ≥40). Retention at the primary endpoint was 82.6%. Mean reductions were 17.0 (therapist-guided I-BA), 16.0 (self-guided I-BA) and 11.6 (TAU), bringing both I-BA groups below the clinical cut-off. Therapist-guided I-BA showed greater reductions than TAU (estimated mean difference −4.68; 95% CI −0.05 to −9.30; p=0.048, d=−0.47; 95% CI 0.00 to −0.93), while self-guided I-BA was not statistically superior (estimated mean difference −3.44; 95% CI −8.05 to 1.17, p=0.14, d=−0.37; 95% CI −0.86 to 0.12). The predefined six-point clinical important difference was not met. Results were sensitive to modelling: significance disappeared with random slopes but effect estimates were similar; baseline-adjusted analyses favoured both I-BA arms. Both I-BA options had lower costs than TAU (p=0.03, p<0.001), with self-guided I-BA being the most economical. Conclusions Therapist-guided I-BA reduced depressive symptoms at lower cost than TAU, but clinical importance and robustness are uncertain. Self-guided I-BA showed no clear superiority but was cost-efficient. Clinical implications Therapist-guided I-BA may increase access to evidence-based care for adolescents with MDD, though findings require cautious interpretation. Self-guided I-BA may be useful where therapist access is limited, but more research is needed.

Read PDF

Similar papers

Open access Aug 2026

Efficacy and cost-effectiveness of Internet-delivered cognitive-behavior therapy for children and adolescents with body dysmorphic disorder: study protocol for a randomized controlled trial

Body dysmorphic disorder (BDD) is a prevalent and impairing mental disorder that typically onsets in adolescence. Cognitive-behavior therapy (CBT) may be effective for adolescent BDD, although the supporting evidence is currently limited. CBT for BDD is a highly specialized treatment, creating a considerable gap in acc...

L. Fernández de la Cruz, Anita Birovecz, Per Andrén et al. · 0 citations
Open access Sep 2026

Therapist-guided Internet-delivered versus Face-to-face CBT for Adults with ADHD: Differential Long-Term Maintenance and Exploratory Correlational Pathways.

OBJECTIVE Therapist-guided Internet-delivered Cognitive Behavioral Therapy (iCBT) offers a promising alternative to face-to-face CBT (FTF-CBT) for adults with attention-deficit/hyperactivity disorder (ADHD), but evidence on its comparative efficacy and long-term maintenance mechanisms is limited. This study aimed to an...

Mei-Rong Pan, S. Zhang, Meng-Jie Zhao et al. · 0 citations
Open access Sep 2026

Internet-based CBT for young adults with low self-esteem: a randomized, controlled study.

BACKGROUND Low self-esteem can be disabling for young individuals, negatively impacting school performance, relationships, and mental or physical health. Cognitive-behavioral conceptualizations and treatments for low self-esteem exist but have not been applied or evaluated in a young adult population. TRIAL DESIGN To...

Matilda Berg, Tomas Lindegaard, Jessica Käll et al. · 0 citations
Open access Aug 2026

A Women-Centered Internet-Based Cognitive Behavioral Therapy for Depressive Symptoms (the 3D Program): Protocol for a Randomized Controlled Trial

If effective, the 3D Program may serve as a scalable, cost-efficient adjunct to routine care for women with depressive symptoms in public health systems, while biomarker findings may lay the groundwork for future trials examining predictors of response.

N. Angarita-Osorio, A. García-Estela, L. Terraneo et al. · 0 citations
Oct 2026

The effect of an integrated application-supported mindfulness-based cognitive therapy programme on depression among adolescents with non-suicidal self-injury: A randomized controlled trial.

OBJECTIVES This study evaluated the effectiveness of an integrated, application-supported mindfulness-based cognitive therapy (MBCT) programme in reducing depressive symptoms among adolescents with non-suicidal self-injury (NSSI). METHODS An open-label, two-arm randomized controlled trial was conducted in two public...

Russunan Jantarapakdee, R. Upasen, Penpaktr Uthis et al. · 0 citations
Open access Sep 2026

Clinical Effectiveness and Cost-Effectiveness of Blended Treatment for Major Depression Compared With Treatment as Usual Within Routine Care in Europe: A Noninferiority Randomized Controlled Trial

BCBT offers an effective and safe digitally supported alternative to face-to-face TAU for patients with MDD and their therapists in routine clinical care and its cost-effectiveness depends on policymakers’ WTP for the additional clinical benefits achieved.

H. Riper, A. Kleiboer, A. Hoogendoorn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.